Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.59 | - |
NAV | ₹107.99 | - |
Fund Started | 11 Nov 2013 | - |
Fund Size | ₹25975.38 Cr | - |
Exit Load | Exit load of 1% for investments beyond 10% if redeemed within 12 months | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 2.65% | - |
3 Year | 19.44% | - |
5 Year | 26.19% | - |
1 Year
3 Year
5 Year
Equity | 91.04% | - |
Cash | -1.87% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Krishna Institute of Medical Sciences Ltd | 2.87% |
CCL Products (India) Ltd. | 2.26% |
Kaynes Technology India Ltd. | 2.21% |
Brigade Enterprises Ltd. | 2.12% |
Cholamandalam Financial Holdings Ltd. | 2.08% |
Multi Commodity Exchange Of India Ltd. | 1.98% |
JB Chemicals & Pharmaceuticals Ltd. | 1.96% |
Blue Star Ltd. | 1.89% |
Nifty 50 | 1.86% |
City Union Bank Ltd. | 1.62% |
Name | Mayank Hyanki | - |
Start Date | 22 Nov 2024 | - |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity & equity related instruments of small cap companies. | - |
Launch Date | 11 Nov 2013 | - |
Description
Launch Date